CURE

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, ...
Targeted Oncology

FDA Clears Larger Vial Size of Nelarabine Injection in T-ALL and T-LBL

The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...

Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma

Orphan drug designation is granted by the FDA for therapies treating rare disease affecting fewer than 200,000 patients in the U.S., and provides development incentives including extended market ...

9-Year-Old Girl Was Suffering with Pain in Her Back and Legs. Weeks Later She Was Diagnosed with a Rare Form of Cancer

Ava Ferguson was diagnosed with acute lymphoblastic leukemia shortly before Christmas ...
Nature

Acute Lymphoblastic Leukemia and Osteonecrosis in Children

Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy, and advances in treatment have significantly improved survival. However, the intensified chemotherapeutic regimens, ...
Targeted Oncology

CTD402 Gains FDA Orphan Drug Designation in T-ALL and T-LBL

CTD402, an allogeneic CAR T-cell therapy, is designed for immediate administration and targets relapsed/refractory T-ALL and ...
CURE

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
Healio

Natural History of Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) manifests as a malignant transformation and proliferation of lymphoid progenitor cells in the bone marrow, blood and eventually extramedullary sites. While mostly ...